New cancer clinical trial: Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor no More Than 4 cm
Published on: August 16, 2017 at 10:00AM
Condition: Lung Adenocarcinoma, Stage I
Intervention: Drug: Pembrolizumab
Sponsor: Samsung Medical Center
Not yet recruiting – verified August 2017
http://ift.tt/2woNP7Q
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM